|Description:||Mouse monoclonal antibody to Insulin.|
|Applications:||IHC, IF, IP|
|Dilutions:||IHC 1:50 - 1:100, IF 1:50 - 1:100, IP 1:20 - 1:50|
|Immunogen:||Recombinant protein of human INS|
|Formulation:||PBS with 0.02% sodium azide, 50% glycerol, pH7.3.|
|Storage:||Store at -20℃. Avoid freeze / thaw cycles.|
Target (Information from UniProt)
|Function:||Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver.|
|Involvement in Disease:||Hyperproinsulinemia: An autosomal dominant condition characterized by elevated levels of serum proinsulin-like material.
Diabetes mellitus, insulin-dependent, 2: A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
Diabetes mellitus, permanent neonatal: A rare form of diabetes distinct from childhood-onset autoimmune diabetes mellitus type 1. It is characterized by insulin-requiring hyperglycemia that is diagnosed within the first months of life. Permanent neonatal diabetes requires lifelong therapy.
Maturity-onset diabetes of the young 10: A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.
|Sequence Similarities:||Belongs to the insulin family.|
Insulin + Proinsulin Antibody
Insulin A chain Antibody
Insulin B chain Antibody
Proinsulin precursor Antibody